Development and validation of a clinical polygenic risk score to predict breast cancer risk

E Hughes, P Tshiaba, S Gallagher, S Wagner… - JCO precision …, 2020 - ascopubs.org
PURPOSE Women with a family history of breast cancer are frequently referred for
hereditary cancer genetic testing, yet< 10% are found to have pathogenic variants in known …
被引用次数：47 相关文章
[HTML] nih.gov

[HTML][HTML] Development and Validation of a Clinical Polygenic Risk Score to Predict Breast Cancer Risk

E Hughes, P Tshiaba, S Gallagher… - JCO Precision …, 2020 - ncbi.nlm.nih.gov
PURPOSE Women with a family history of breast cancer are frequently referred for
hereditary cancer genetic testing, yet< 10% are found to have pathogenic variants in known …

Development and Validation of a Clinical Polygenic Risk Score to Predict Breast Cancer Risk

E Hughes, P Tshiaba, S Gallagher… - JCO precision …, 2020 - pubmed.ncbi.nlm.nih.gov
Purpose Women with a family history of breast cancer are frequently referred for hereditary
cancer genetic testing, yet< 10% are found to have pathogenic variants in known breast …

Development and Validation of a Clinical Polygenic Risk Score to Predict Breast Cancer Risk.

E Hughes, P Tshiaba, S Gallagher, S Wagner… - JCO Precision …, 2020 - europepmc.org
Purpose Women with a family history of breast cancer are frequently referred for hereditary
cancer genetic testing, yet< 10% are found to have pathogenic variants in known breast …